|1.||Jiang, Xian-Zhen: 1 article (08/2013)|
|2.||Wang, Ya-Qin: 1 article (08/2013)|
|3.||Huang, Fei-Zhou: 1 article (08/2013)|
|4.||Wang, Chang-Fa: 1 article (08/2013)|
|5.||Liu, Xun-Yang: 1 article (08/2013)|
|6.||Nie, Wan-Pin: 1 article (08/2013)|
|7.||Ogawa, Kenji: 1 article (07/2008)|
|8.||Yoshimatsu, Kazuhiko: 1 article (07/2008)|
|9.||Naritaka, Yoshihiko: 1 article (07/2008)|
|10.||Shimakawa, Takeshi: 1 article (07/2008)|
|2.||Esophageal Neoplasms (Esophageal Cancer)
09/01/1995 - "This FAP regimen is suspected to be useful chemotherapy for advanced esophageal cancer."
07/01/2008 - "This study was performed to assess the usefulness and safety of neoadjuvant chemotherapy utilizing the FAP regimen consisting of 5-fluorouracil, cisplatin and adriamycin for the treatment of highly advanced esophageal cancer. "
|4.||Hepatocellular Carcinoma (Hepatoma)
08/01/2013 - "The combined use of methyl jasmonate and the FAP regimen might be a novel strategy for overcoming the multidrug resistance often observed in hepatocellular carcinoma."
08/01/2013 - "Multidrug resistant H22 (H22/FAP) hepatocellular carcinoma cells were produced in vitro by continuous exposure to increasing doses of doxorubicin, cisplatin and 5-fluorouracil (FAP regimen). "
|1.||Drug Therapy (Chemotherapy)